STANFORD HEALTH CARE
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $14.1M
- Transactions
- 1,031
- Companies
- 40
- Average per transaction
- $13,713
Who reported the payments
| Takeda Pharmaceuticals U.S.A., Inc. | $2,122,695 |
| Orthofix Medical, Inc. | $1,802,316 |
| Medtronic | $1,163,169 |
| Servier Bioinnovation | $788,483 |
| Novartis | $736,961 |
| Reflexion Medical, Inc. | $666,158 |
| Pfizer | $656,967 |
| GE HealthCare | $640,330 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | $542,534 |
| Adaptive Biotechnologies Corporation | $394,291 |
| Sarepta Therapeutics, Inc. | $389,910 |
| Servier Pharmaceuticals LLC | $326,900 |
| National Marrow Donor Program | $280,835 |
| Abbott | $276,300 |
| AbbVie | $261,893 |
| Stryker | $254,867 |
| Surgical Theater. Inc. | $243,000 |
| Cathworks, Inc. | $204,524 |
| Boehringer Ingelheim | $175,750 |
| Varian Medical Systems, Inc. | $153,000 |
| Philips North America LLC | $150,000 |
| Angiodynamics, Inc. | $148,214 |
| Acumed LLC | $142,000 |
| Olympus America Inc. | $139,892 |
| KCI USA, Inc. | $135,295 |
| Jazz Pharmaceuticals Inc. | $115,597 |
| Monteris Medical Corporation | $113,050 |
| Progenics Pharmaceuticals, Inc. | $83,600 |
| Agios Pharmaceuticals, Inc. | $82,110 |
| Soleno Therapeutics, Inc. | $69,503 |
| Solventum Corporation | $68,662 |
| Elekta Limited | $60,000 |
| Xvivo Perfusion Inc. | $55,158 |
| Biogen | $50,837 |
| Medartis Inc. | $47,753 |
| Daiichi Sankyo Inc. | $42,973 |
| Shockwave Medical, Inc | $40,991 |
| Johnson & Johnson | $38,515 |
| Med-el Corporation | $34,080 |
| Blackswan Vascular, Inc. | $34,035 |